Reviewing Haoxi Health Technology (NASDAQ:HAO) and John Wiley & Sons (NYSE:WLY)

Haoxi Health Technology (NASDAQ:HAO) and John Wiley & Sons (NYSE:WLY) are both communication services companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Dividends

Haoxi Health Technology pays an annual dividend of $0.70 per share and has a dividend yield of 23.3%. John Wiley & Sons pays an annual dividend of $1.43 per share and has a dividend yield of 2.7%. John Wiley & Sons pays out 33.8% of its earnings in the form of a dividend. John Wiley & Sons has increased its dividend for 26 consecutive years.

Profitability

This table compares Haoxi Health Technology and John Wiley & Sons’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Haoxi Health Technology	N/A	N/A	N/A
John Wiley & Sons	13.22%	29.01%	8.78%

Volatility & Risk

Haoxi Health Technology has a beta of -1.13, suggesting that its stock price is 213% less volatile than the S&P 500. Comparatively, John Wiley & Sons has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings for Haoxi Health Technology and John Wiley & Sons, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haoxi Health Technology	1	0	0	0	1.00
John Wiley & Sons	0	1	1	0	2.50

Valuation & Earnings

This table compares Haoxi Health Technology and John Wiley & Sons”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haoxi Health Technology	$42.68 million	0.03	$3.88 million	N/A	N/A
John Wiley & Sons	$1.68 billion	1.61	$221.62 million	$4.23	12.56

John Wiley & Sons has higher revenue and earnings than Haoxi Health Technology.

Insider and Institutional Ownership

73.9% of John Wiley & Sons shares are held by institutional investors. 17.6% of John Wiley & Sons shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

John Wiley & Sons beats Haoxi Health Technology on 12 of the 14 factors compared between the two stocks.

About Haoxi Health Technology

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.

About John Wiley & Sons

John Wiley & Sons, Inc. engages in the provision of research and learning materials. It operates through the following segments: Research, Learning, and Held for Sale or Sold. The Research segment consists of research publishing and research solutions. The Learning segment includes academic and professional reporting lines and consists of publishing and related knowledge solutions. The Held for Sale or Sold segment offers businesses held-for-sale including Wiley Edge and CrossKnowledge, University Services and Tuition Manager, and Test Prep and Advancement Courses. The company was founded by Charles Wiley in 1807 and is headquartered in Hoboken, NJ.